Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2015. Start Trial.
Date Value
December 31, 2025 -9.377M
December 31, 2024 -23.95M
December 31, 2023 -31.91M
December 31, 2022 -27.74M
December 31, 2021 -32.63M
December 31, 2020 -27.31M
Date Value
December 31, 2019 -28.98M
December 31, 2018 -15.00M
December 31, 2017 -11.01M
December 31, 2016 -11.92M
December 31, 2015 -6.371M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc -7.268M
Mereo BioPharma Group Plc -31.04M
BioNTech SE 514.63M
Silence Therapeutics Plc -62.27M
Compass Pathways Plc -157.61M